Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion type Assertion NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_head.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion evidence source_evidence_literature NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion SIO_000772 16633151 NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion wasDerivedFrom gad-20150221 NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion wasGeneratedBy ECO_0000203 NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.